A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Clinical trial NCT06982859 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06982859
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-02
- Primary completion
- 2026-12-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.